{
    "5600": {
        "explanation_text": "Drug or chemical induced diabetes mellitus without complications.",
        "symptom_text": "The patient has a history of chronic pain due to osteoarthritis and has been on long-term nonsteroidal anti-inflammatory drugs (NSAIDs) for pain management.The patient complains of increased thirst and frequent urination over the last few weeks.Fasting blood glucose level: 210 mg/dL, HbA1c: 7.5%, Urinalysis: Glucose present, Ketones negative.Drug or chemical induced diabetes mellitus without complications. Verbatim EHR quote justifying the code: 'The patient's symptoms, elevated fasting blood glucose level, HbA1c of 7.5%, and presence of glucose in the urine are consistent with drug-induced diabetes mellitus without complications.'Patient denies any family history of diabetes. No signs of diabetic neuropathy or retinopathy on examination.Initiated lifestyle modifications, dietary changes, and prescribed metformin for glycemic control.Patient educated on diabetes management, advised to monitor blood glucose levels regularly, and scheduled for a follow-up in two weeks.58FemaleCaucasian"
    },
    "5601": {
        "explanation_text": "Type 1 diabetes mellitus with ketoacidosis without coma.",
        "symptom_text": "The patient has a known medical history of Type 1 diabetes mellitus.The patient presents with symptoms of polyuria, polydipsia, weight loss, fatigue, and abdominal pain.Laboratory tests show hyperglycemia, ketonemia, and metabolic acidosis.Type 1 diabetes mellitus with ketoacidosis without coma.The patient's blood glucose levels were significantly elevated, and arterial blood gas analysis revealed metabolic acidosis with an increased anion gap, confirming the diagnosis of diabetic ketoacidosis.The patient was treated with intravenous fluids, insulin therapy, and electrolyte replacement.The patient responded well to treatment and was discharged home with instructions for insulin therapy and close follow-up with the endocrinology team.32FemaleCaucasian"
    },
    "5602": {
        "explanation_text": "Type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema.",
        "symptom_text": "The patient has a known history of Type 1 diabetes mellitus.The patient reports no specific visual disturbances or changes in vision.Ophthalmologic examination revealed diabetic retinopathy without macular edema.Type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema. Verbatim ICD-10-CM justification: 'Type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema.'Patient's blood glucose levels are well-controlled with insulin therapy. No signs of diabetic nephropathy or other diabetic eye complications were noted.Continuation of insulin therapy, regular ophthalmology follow-ups, and diabetic education.The patient was discharged in stable condition with instructions to monitor blood glucose levels regularly and attend scheduled ophthalmology appointments.42FemaleCaucasian"
    },
    "5603": {
        "explanation_text": "Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral.",
        "symptom_text": "The patient has a known medical history of Type 1 diabetes mellitus without any complications. There is no history of drug or chemical-induced diabetes, diabetic neuropathy, ketoacidosis, diabetic nephropathy, or other diabetic ophthalmic complications.The patient is asymptomatic for any neurological complications, hypoglycemia, hyperglycemia, ketoacidosis, diabetic nephropathy, or proliferative diabetic retinopathy. The only symptom present is mild nonproliferative diabetic retinopathy without macular edema in both eyes.Ophthalmologic examination results indicate the presence of mild nonproliferative diabetic retinopathy without macular edema in both eyes. Blood tests show well-controlled blood glucose levels with no signs of ketoacidosis or other complications.Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral. Verbatim EHR quote justifying the code: 'Patient presents with Type 1 diabetes mellitus and mild nonproliferative diabetic retinopathy without macular edema in both eyes.'The patient's overall health is stable with well-controlled blood glucose levels. There are no signs of systemic complications related to diabetes. Ophthalmologic evaluation confirms the presence of mild nonproliferative diabetic retinopathy without macular edema in both eyes.The patient is advised to continue with their current diabetes management plan, including insulin therapy and regular ophthalmology follow-ups for diabetic retinopathy monitoring.42FemaleCaucasian"
    },
    "5604": {
        "explanation_text": "Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye.",
        "symptom_text": "The patient has a known history of Type 1 diabetes mellitus.The patient is asymptomatic for any visual disturbances or eye-related symptoms.Ophthalmologic examination revealed mild nonproliferative diabetic retinopathy without macular edema in the unspecified eye.Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye (E103299).The patient's diabetes management is stable. No signs of macular edema were noted during the examination.Continuation of current diabetes treatment regimen with regular ophthalmology follow-up.The patient was discharged in stable condition with instructions to monitor blood sugar levels regularly and attend scheduled ophthalmology appointments.45FemaleCaucasian"
    },
    "5605": {
        "explanation_text": "Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral.",
        "symptom_text": "The patient was diagnosed with Type 1 diabetes mellitus several years ago and has been managing it with insulin therapy. There is a history of regular ophthalmic examinations due to diabetic retinopathy.The patient complains of blurred vision, floaters, and difficulty seeing at night. There is no history of drug or chemical-induced diabetes, hypoglycemia, or hyperglycemia.Ophthalmologic examination revealed bilateral proliferative diabetic retinopathy with macular edema. Fundoscopy showed neovascularization, microaneurysms, and macular edema.Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral: The presence of neovascularization, microaneurysms, and macular edema in both eyes confirms the diagnosis of Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral.The patient's blood glucose levels have been relatively stable with insulin therapy. Referral to an ophthalmologist for further management of the diabetic retinopathy has been made.The patient was advised to continue insulin therapy as prescribed. Ophthalmology consult recommended for possible laser photocoagulation or anti-VEGF therapy.45FemaleCaucasian"
    },
    "5606": {
        "explanation_text": "Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral.",
        "symptom_text": "The patient has a known history of Type 1 diabetes mellitus.The patient is asymptomatic for any visual disturbances or eye-related symptoms.Ophthalmologic examination revealed bilateral proliferative diabetic retinopathy without macular edema.Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral. The patient has no macular edema, distinguishing this code from others.The patient's diabetes management is stable. Referral to an ophthalmologist for further evaluation and management of proliferative diabetic retinopathy without macular edema.The patient is advised to continue current diabetes treatment regimen. Ophthalmology follow-up scheduled.42FemaleCaucasian"
    },
    "5607": {
        "explanation_text": "Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye.",
        "symptom_text": "The patient has a long-standing history of Type 1 diabetes mellitus diagnosed X years ago. The patient has been compliant with insulin therapy and regular follow-ups.The patient reports no new symptoms related to the eyes. Denies any visual disturbances, floaters, flashes of light, or vision loss.Recent fundoscopic examination revealed findings consistent with proliferative diabetic retinopathy without macular edema in the unspecified eye.Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye. Verbatim EHR quote justifying the code: 'Recent fundoscopic examination revealed findings consistent with proliferative diabetic retinopathy without macular edema in the unspecified eye.'Patient educated on the importance of strict glycemic control to prevent further progression of diabetic retinopathy. Follow-up ophthalmology appointment scheduled in 3 months.Continuation of insulin therapy with close monitoring of blood glucose levels. Referral to ophthalmology for further management of proliferative diabetic retinopathy.42FemaleCaucasian"
    },
    "5608": {
        "explanation_text": "Type 1 diabetes mellitus with other diabetic ophthalmic complication.",
        "symptom_text": "The patient has a known history of Type 1 diabetes mellitus.The patient complains of blurred vision, floaters, and vision loss in both eyes.Fundoscopic examination shows findings consistent with diabetic retinopathy without macular edema or proliferative changes.Diagnosis: Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema (ICD-10-CM code E1039).The patient presented with classic symptoms of diabetic retinopathy without evidence of other diabetic complications. Fundoscopy revealed characteristic changes of proliferative diabetic retinopathy without macular edema. No signs of diabetic nephropathy or neuropathy were noted.The patient is advised to maintain strict glycemic control, undergo regular ophthalmic follow-ups, and consider laser treatment for the retinopathy.The patient was discharged with instructions for diabetic management and a referral to an ophthalmologist for further evaluation and treatment of the proliferative diabetic retinopathy.45MaleCaucasian"
    },
    "5609": {
        "explanation_text": "Type 1 diabetes mellitus with diabetic neuropathy, unspecified.",
        "symptom_text": "The patient has a history of Type 1 diabetes mellitus diagnosed five years ago. The patient has been managing their diabetes with insulin therapy.The patient presents with symptoms of tingling and numbness in both feet, which have been progressively worsening over the last few months. The patient also reports difficulty walking and a burning sensation in the feet.Nerve conduction studies revealed reduced nerve conduction velocity and abnormal sensory nerve action potentials in the lower extremities, consistent with diabetic neuropathy.Type 1 diabetes mellitus with diabetic neuropathy, unspecified.Patient's physical examination shows decreased sensation to light touch and pinprick in both feet. Deep tendon reflexes are diminished. No signs of diabetic retinopathy or other diabetic complications were noted.Initiated gabapentin for neuropathic pain management. Recommended regular podiatry visits and foot care education to prevent foot ulcers.The patient responded well to treatment and education on foot care. Discharged home with a follow-up appointment in two weeks.42FemaleCaucasian"
    },
    "5610": {
        "explanation_text": "Type 1 diabetes mellitus with diabetic polyneuropathy.",
        "symptom_text": "The patient has a known medical history of Type 1 diabetes mellitus.The patient presents with neuropathic pain, tingling, and numbness in the lower extremities.Nerve conduction studies revealed peripheral nerve damage consistent with diabetic polyneuropathy.Type 1 diabetes mellitus with diabetic polyneuropathy. Verbatim EHR quote justifying the code: 'The patient is diagnosed with Type 1 diabetes mellitus with diabetic polyneuropathy.'The patient reports worsening neuropathic symptoms over the past few months, affecting daily activities.The patient was started on gabapentin for neuropathic pain management and advised on diabetic foot care.The patient's symptoms improved with treatment, and they were discharged with a follow-up appointment in two weeks.45FemaleCaucasian"
    },
    "5611": {
        "explanation_text": "Type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy.",
        "symptom_text": "The patient has a history of Type 1 diabetes mellitus diagnosed 10 years ago.The patient presents with symptoms of diabetic autonomic neuropathy, including gastroparesis, postural hypotension, and anhidrosis.Autonomic function testing revealed abnormalities consistent with diabetic autonomic neuropathy.Type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy (E1043)Patient exhibits classic symptoms of diabetic autonomic neuropathy, including gastrointestinal issues, orthostatic hypotension, and lack of sweating. Autonomic function testing confirmed the presence of diabetic autonomic neuropathy.Initiated treatment with pregabalin for neuropathic pain and recommended dietary modifications for gastroparesis.The patient responded well to treatment and was discharged with a follow-up scheduled in 3 months.45FemaleCaucasian"
    },
    "5612": {
        "explanation_text": "Type 1 diabetes mellitus with diabetic peripheral angiopathy with gangrene.",
        "symptom_text": "The patient has a known history of Type 1 diabetes mellitus.The patient presents with symptoms of pain, discoloration, and tissue decay in the lower extremities.Vascular studies show impaired blood flow to the lower limbs. Imaging reveals areas of tissue necrosis consistent with gangrene.Type 1 diabetes mellitus with diabetic peripheral angiopathy with gangrene (E1052).Physical examination indicates signs of peripheral vascular disease with gangrenous changes in the feet.The patient is started on insulin therapy for diabetes management. Surgical consultation is obtained for debridement of gangrenous tissue and possible amputation if necessary.The patient responded well to treatment and is scheduled for follow-up care with the endocrinology and surgical teams post-discharge.55MaleCaucasian"
    },
    "5613": {
        "explanation_text": "Type 1 diabetes mellitus with other skin ulcer.",
        "symptom_text": "The patient has a known history of Type 1 diabetes mellitus for the past 10 years.The patient presents with a non-healing skin ulcer on the left forearm, measuring 2 cm in diameter. No signs of infection or gangrene noted.HbA1c level is 8.5%. Doppler ultrasound shows adequate blood flow to the affected area.Type 1 diabetes mellitus with other skin ulcer (ICD-10-CM code E10622): Non-healing skin ulcer on the left forearm.The patient reports no history of trauma to the area. The ulcer is superficial with no involvement of deeper tissues. No signs of neuropathy or vascular compromise.Prescribed daily wound care with saline dressings. Adjusted insulin regimen to improve glycemic control.The patient's blood glucose levels are better controlled, and the ulcer shows signs of healing. Discharged with instructions for wound care and follow-up in the diabetic clinic in two weeks.45FemaleCaucasian"
    },
    "5614": {
        "explanation_text": "Type 1 diabetes mellitus with unspecified complications.",
        "symptom_text": "The patient has a known history of Type 1 diabetes mellitus without any specific complications.The patient presents with polyuria, polydipsia, unexplained weight loss, and fatigue.Laboratory tests show elevated blood glucose levels and glycosylated hemoglobin (HbA1c) consistent with poorly controlled diabetes.Type 1 diabetes mellitus with unspecified complications. Verbatim EHR quote justifying the code: 'The patient has a known history of Type 1 diabetes mellitus without any specific complications.'The patient's diabetes management plan includes insulin therapy, dietary modifications, and regular blood glucose monitoring.The patient is prescribed insulin injections, advised on carbohydrate counting, and scheduled for diabetic education sessions.32FemaleCaucasian"
    },
    "5615": {
        "explanation_text": "Type 2 diabetes mellitus with ketoacidosis without coma.",
        "symptom_text": "The patient has a medical history of Type 2 diabetes mellitus.The patient presents with polyuria, polydipsia, and abdominal pain.Laboratory results indicate high blood glucose levels, low bicarbonate levels, and low pH.Type 2 diabetes mellitus with ketoacidosis without coma (E11.10): The patient is diagnosed with Type 2 diabetes mellitus with ketoacidosis without coma.The patient's ketone levels are elevated, indicating ketoacidosis without coma.The patient is being treated with intravenous fluids, insulin therapy, and close monitoring of electrolyte levels.The patient responded well to treatment and was discharged in stable condition.55FemaleCaucasian"
    },
    "5616": {
        "explanation_text": "Type 2 diabetes mellitus with diabetic nephropathy.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus and hypertension.The patient complains of increased urination, excessive thirst, and fatigue.Laboratory tests revealed elevated serum creatinine levels and abnormal urinary albumin excretion.Type 2 diabetes mellitus with diabetic nephropathyThe patient presents with classic symptoms of Type 2 diabetes mellitus and has evidence of diabetic nephropathy on diagnostic tests. Treatment plan includes managing blood glucose levels and blood pressure to slow the progression of nephropathy.Prescribed metformin for diabetes management and ACE inhibitors for nephropathy.The patient was stable at discharge with instructions to continue medications and follow up with the endocrinologist and nephrologist.55FemaleCaucasian"
    },
    "5617": {
        "explanation_text": "Type 2 diabetes mellitus with other diabetic kidney complication.",
        "symptom_text": "The patient has a longstanding history of Type 2 diabetes mellitus diagnosed 10 years ago. The diabetes has been managed with oral hypoglycemic agents.The patient complains of increasing fatigue, swelling in the legs, and decreased urine output.Laboratory tests reveal elevated serum creatinine levels and abnormal urinary protein excretion, indicating kidney involvement.Type 2 diabetes mellitus with other diabetic kidney complication - E1129: The type 2 diabetes mellitus has led to diabetic kidney complications as evidenced by elevated serum creatinine levels and abnormal urinary protein excretion.The patient presents with signs of diabetic kidney disease with evidence of declining kidney function. Nephrology consult recommended for further management.Treatment includes optimization of diabetes management, initiation of ACE inhibitors for renal protection, and dietary modifications to reduce proteinuria.The patient is stable with improved symptoms and renal function. Discharged with close follow-up with a nephrologist.60FemaleCaucasian"
    },
    "5618": {
        "explanation_text": "Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus and has been monitoring blood glucose levels regularly.The patient complains of blurred vision and mild eye pain in both eyes.Ophthalmologic examination revealed macular edema in both eyes, confirming the diagnosis of diabetic retinopathy.Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema (E11311): The patient presents with Type 2 diabetes mellitus and diabetic retinopathy with macular edema, as evidenced by ophthalmologic examination findings.The patient's blood glucose levels are within the target range, and no signs of other diabetic complications were noted during the physical examination.The patient was advised to continue with their current diabetes management plan, including medication adherence and regular ophthalmology follow-ups for diabetic retinopathy monitoring.The patient was discharged in stable condition with instructions to follow up with both the endocrinology and ophthalmology departments for ongoing management of Type 2 diabetes mellitus and diabetic retinopathy with macular edema.55FemaleCaucasian"
    },
    "5619": {
        "explanation_text": "Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus and has been managing the condition with oral antidiabetic medication for the past 5 years.The patient is asymptomatic for macular edema, presenting with stable vision and no complaints related to the eyes.Recent fundoscopic examination showed evidence of mild nonproliferative diabetic retinopathy without macular edema.Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema. Verbatim EHR snippet justifying the code: 'Recent fundoscopic examination revealed mild nonproliferative diabetic retinopathy without macular edema.'The patient's blood glucose levels have been relatively controlled with an HbA1c of 7.2%. No signs of macular edema or other diabetic eye complications were noted during the examination.The patient will continue the current antidiabetic medication regimen, and annual ophthalmologic follow-ups were advised for diabetic retinopathy monitoring.58FemaleCaucasian"
    },
    "5620": {
        "explanation_text": "Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus under management.The patient reports mild vision changes but denies any vision loss or distortion.Ophthalmologic exam results show moderate nonproliferative diabetic retinopathy without macular edema.Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye. Verbatim EHR quote justifying the code: 'Moderate nonproliferative diabetic retinopathy without macular edema confirmed on ophthalmologic exam.'Patient's blood glucose levels are within target range. Recommend annual eye exams to monitor retinopathy progression.Prescribed oral hypoglycemic agents for diabetes management. Referral to ophthalmology for regular diabetic retinopathy monitoring.58FemaleCaucasian"
    },
    "5621": {
        "explanation_text": "Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye.",
        "symptom_text": "The patient has a history of type 2 diabetes mellitus.The patient complains of blurred vision and occasional floaters in the vision.Fundoscopic examination revealed microaneurysms, retinal hemorrhages, and cotton-wool spots consistent with severe nonproliferative diabetic retinopathy without macular edema.Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye. Verbatim EHR quote justifying the code: 'Fundoscopic examination revealed microaneurysms, retinal hemorrhages, and cotton-wool spots consistent with severe nonproliferative diabetic retinopathy without macular edema.'The patient's blood glucose levels are well-controlled with current medication. Advised the patient on the importance of regular eye examinations and diabetic management.Prescribed diabetic retinopathy monitoring every 6 months, continuation of current diabetes medication, and lifestyle modifications.The patient was discharged in stable condition with a follow-up appointment scheduled in 6 months.58FemaleCaucasian"
    },
    "5622": {
        "explanation_text": "Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus.The patient complains of intermittent blurred vision in the right eye.Fundoscopic examination reveals neovascularization and vitreous hemorrhage in the right eye consistent with proliferative diabetic retinopathy without macular edema.Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye (E113591).The patient has characteristic findings of proliferative diabetic retinopathy in the right eye without macular edema.Initiated laser photocoagulation therapy to manage the proliferative changes in the right eye.The patient was discharged with a scheduled follow-up in the ophthalmology clinic for further evaluation of the retinopathy.55FemaleCaucasian"
    },
    "5623": {
        "explanation_text": "Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye.",
        "symptom_text": "The patient has a history of type 2 diabetes mellitus and has been undergoing regular ophthalmic examinations due to diabetic retinopathy.The patient is asymptomatic for any visual disturbances or changes in vision.Ophthalmologic examination revealed proliferative diabetic retinopathy without macular edema in the left eye.Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye.The patient's ophthalmologic examination confirmed the presence of proliferative diabetic retinopathy without macular edema in the left eye. No signs of macular edema were noted during the examination.The patient was advised to continue with their current diabetes management plan and to follow up regularly with the ophthalmologist for monitoring.The patient was discharged in stable condition with instructions to maintain glycemic control and attend scheduled follow-up appointments.58FemaleCaucasian"
    },
    "5624": {
        "explanation_text": "Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus and has been undergoing regular ophthalmic examinations due to diabetic retinopathy.The patient reported no specific ocular symptoms such as blurriness, distorted vision, or floaters.Fundoscopic examination revealed bilateral proliferative changes consistent with diabetic retinopathy without macular edema.Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral. The patient has bilateral proliferative diabetic retinopathy without macular edema.The patient's retinal examination showed characteristic findings of proliferative diabetic retinopathy with no signs of macular edema. The condition is bilateral.The patient was advised to maintain strict glycemic control, continue regular ophthalmic follow-ups, and consider laser photocoagulation therapy.55FemaleCaucasian"
    },
    "5625": {
        "explanation_text": "Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye.",
        "symptom_text": "The patient has a history of type 2 diabetes mellitus and has been managing their condition with oral antidiabetic medications for the past 5 years.The patient reports seeing dark spots in their vision and occasional vision loss in the right eye.Fundoscopic examination revealed new vessels at the optic disc with no signs of macular edema on optical coherence tomography (OCT).Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye. The patient presents with new vessels at the optic disc on fundoscopic examination, characteristic of proliferative diabetic retinopathy without macular edema.The patient's condition requires close monitoring to prevent further vision loss. Referral to an ophthalmologist for possible laser photocoagulation therapy is recommended.The patient has been prescribed topical ocular hypotensive agents to manage intraocular pressure and advised on strict glycemic control.The patient was discharged in stable condition with scheduled follow-up appointments with both the endocrinologist and ophthalmologist.58FemaleCaucasian"
    },
    "5626": {
        "explanation_text": "Type 2 diabetes mellitus with other diabetic ophthalmic complication.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus for the past 10 years.The patient presents with blurred vision and floaters in both eyes.Ophthalmic examination revealed proliferative diabetic retinopathy without macular edema.Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema (E1139)Patient's ophthalmic examination confirmed the presence of proliferative diabetic retinopathy without macular edema. No signs of diabetic macular edema or other ophthalmic complications were noted.Initiated laser photocoagulation therapy for diabetic retinopathy. Recommended strict glycemic control and regular ophthalmic follow-ups.Patient responded well to treatment and was discharged with a follow-up appointment in one month.58FemaleCaucasian"
    },
    "5627": {
        "explanation_text": "Type 2 diabetes mellitus with diabetic neuropathy, unspecified.",
        "symptom_text": "The patient has a history of type 2 diabetes mellitus.The patient presents with numbness, tingling, and pain in the feet and hands.Nerve conduction studies revealed peripheral neuropathy consistent with diabetic neuropathy.Type 2 diabetes mellitus with diabetic neuropathy, unspecified (E1140).The patient reports gradual onset of neuropathic symptoms over the past few months. Physical examination shows decreased sensation in the distal extremities. Nerve conduction studies confirm the presence of diabetic neuropathy.Initiated treatment with gabapentin for neuropathic pain management. Recommended regular foot care and blood sugar monitoring.The patient was discharged with a treatment plan for diabetic neuropathy and advised to follow up with the endocrinologist for diabetes management.58FemaleCaucasian"
    },
    "5628": {
        "explanation_text": "Type 2 diabetes mellitus with diabetic polyneuropathy.",
        "symptom_text": "The patient has a history of poorly controlled Type 2 diabetes mellitus.The patient presents with bilateral lower extremity numbness, tingling, and burning pain exacerbated at night. There are no symptoms of diabetic retinopathy, cataract, or mononeuropathy.Nerve conduction studies revealed symmetric sensorimotor polyneuropathy consistent with diabetic neuropathy.Type 2 diabetes mellitus with diabetic polyneuropathy (E1142).The patient's symptoms and diagnostic tests are consistent with diabetic polyneuropathy. No signs of other diabetic neurological complications were observed.Initiated treatment with pregabalin for neuropathic pain management. Recommended strict glycemic control and regular foot care.The patient responded well to treatment and education on diabetic neuropathy. Discharged with a follow-up appointment in three months.58MaleCaucasian"
    },
    "5629": {
        "explanation_text": "Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy.",
        "symptom_text": "The patient has a history of poorly controlled Type 2 diabetes mellitus for the past 10 years.The patient presents with symptoms of gastroparesis, orthostatic hypotension, persistent diarrhea, and impaired sweating.Autonomic function tests revealed abnormalities consistent with autonomic neuropathy.Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy (E1143)The patient's symptoms and diagnostic test results are indicative of diabetic autonomic neuropathy. The patient requires close monitoring and management to prevent complications.Initiated treatment with a tailored diabetic diet, insulin therapy, and medications to manage autonomic neuropathy symptoms.The patient was discharged with instructions to follow up with endocrinology for further management of diabetes and neuropathy.55FemaleCaucasian"
    },
    "5630": {
        "explanation_text": "Type 2 diabetes mellitus with other diabetic neurological complication.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus and has been managing it with oral hypoglycemic agents for the past five years.The patient presents with symptoms of tingling and numbness in both feet, loss of balance, and difficulty in controlling bladder function.Nerve conduction studies revealed peripheral neuropathy with decreased nerve conduction velocities and altered sensory nerve action potentials.Type 2 diabetes mellitus with other diabetic neurological complication. Verbatim EHR quote justifying the code: 'Patient diagnosed with Type 2 diabetes mellitus presenting with symptoms of peripheral neuropathy including tingling and numbness in both feet, loss of balance, and altered bladder function.'Patient reports progressive worsening of symptoms over the last six months. Physical examination shows decreased sensation in both lower extremities and absent ankle reflexes.Initiated treatment with pregabalin for neuropathic pain management and referred the patient to a neurologist for further evaluation.The patient responded well to treatment and showed improvement in neuropathic symptoms. Discharged home with a follow-up appointment scheduled with the neurology department in two weeks.58MaleCaucasian"
    },
    "5631": {
        "explanation_text": "Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus and has been managing blood sugar levels with oral medications for the past 5 years.The patient presents with numbness and tingling in the lower extremities, cool skin in the legs, diminished pulses in the feet, and intermittent claudication.Ankle-brachial index (ABI) test revealed decreased values indicating peripheral arterial disease. Doppler ultrasound showed reduced blood flow in the lower limbs without evidence of arterial occlusion or gangrene.Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene. Verbatim EHR quote justifying the code: 'Patient diagnosed with Type 2 diabetes mellitus presenting with symptoms of peripheral vascular disease, including numbness, cool skin, diminished pulses, and intermittent claudication. Diagnostic tests confirmed peripheral angiopathy without evidence of gangrene.'Patient's blood pressure is well-controlled. Advised patient on lifestyle modifications, including regular exercise and smoking cessation. Started patient on antiplatelet therapy and referred to a vascular specialist for further management.Prescribed aspirin for antiplatelet therapy. Recommended a low-fat diet and regular exercise routine. Advised the patient to follow up with the vascular specialist for ongoing care.Patient discharged in stable condition with prescriptions for aspirin and follow-up appointment with the vascular specialist in two weeks.58MaleCaucasian"
    },
    "5632": {
        "explanation_text": "Type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene.",
        "symptom_text": "The patient has a longstanding history of poorly controlled type 2 diabetes mellitus.The patient presents with a non-healing ulcer on the left foot with visible gangrene. The affected area is cold to touch and shows signs of infection.Vascular studies reveal significant peripheral arterial disease with compromised blood flow to the left foot. Imaging confirms the presence of gangrene.Type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene (E1152): The gangrenous changes in the left foot are consistent with diabetic peripheral angiopathy with gangrene.The patient requires urgent surgical intervention to address the gangrenous tissue and improve blood flow to the affected foot.The patient underwent surgical debridement of the gangrenous tissue and received intravenous antibiotics to treat the infection. Postoperatively, the patient was started on anticoagulant therapy and scheduled for regular wound care.The patient responded well to treatment and was discharged with instructions for wound care, glycemic control, and follow-up appointments for vascular assessment.65MaleCaucasian"
    },
    "5633": {
        "explanation_text": "Type 2 diabetes mellitus with other circulatory complications.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus for the past 10 years with well-controlled blood glucose levels. The patient has a family history of diabetes but no history of diabetic eye disease, neuropathy, or skin complications.The patient complains of intermittent chest pain on exertion and occasional shortness of breath. No visual disturbances, eye pain, or skin ulcers reported.Fasting blood glucose levels are within the target range. Lipid profile shows slightly elevated LDL cholesterol levels. ECG indicates normal sinus rhythm with no acute changes.Type 2 diabetes mellitus with other circulatory complicationsThe patient presents with stable blood glucose levels and controlled hypertension. There are no signs of diabetic retinopathy, neuropathy, or skin complications. Given the patient's symptoms of chest pain and shortness of breath, further cardiological evaluation is recommended.The patient is advised to continue the current diabetic management regimen with regular monitoring. A cardiology consult is scheduled to assess the chest pain and shortness of breath.The patient was stable throughout the hospital stay. Discharged with instructions for diabetic care and a follow-up appointment with the cardiologist.58MaleCaucasian"
    },
    "5634": {
        "explanation_text": "Type 2 diabetes mellitus with diabetic neuropathic arthropathy.",
        "symptom_text": "The patient has a longstanding history of Type 2 diabetes mellitus, well-controlled with oral hypoglycemic agents.The patient complains of chronic pain and swelling in the right foot with limited range of motion at the ankle joint.X-ray of the right foot shows degenerative changes in the ankle joint consistent with neuropathic arthropathy.Type 2 diabetes mellitus with diabetic neuropathic arthropathy (E11.610)Clinical examination reveals Charcot joint deformity in the right foot, confirming the diagnosis of diabetic neuropathic arthropathy.The patient was advised strict offloading of the affected foot, referred to orthopedics for further management, and instructed on glucose control measures.The patient was discharged in stable condition with scheduled follow-up appointments for wound care and diabetic management.55MaleCaucasian"
    },
    "5635": {
        "explanation_text": "Type 2 diabetes mellitus with hypoglycemia without coma.",
        "symptom_text": "The patient has a known medical history of Type 2 diabetes mellitus.The patient presents with sweating, confusion, and dizziness, consistent with hypoglycemia.Blood glucose level of 55 mg/dL confirming hypoglycemia, HbA1c of 7.8% indicating uncontrolled diabetes.Type 2 diabetes mellitus with hypoglycemia without coma. Verbatim EHR quote justifying the code: 'Patient diagnosed with Type 2 diabetes mellitus presenting with hypoglycemia symptoms and confirmed low blood glucose levels.'The physician notes the patient's altered mental status resolved promptly with glucose administration. No signs of neurological deficits or skin complications observed.The patient was treated with oral glucose tablets, counseled on diabetic management, and discharged with instructions for glucose monitoring.The patient responded well to treatment, symptoms resolved, and was discharged in stable condition.55MaleCaucasian"
    },
    "5636": {
        "explanation_text": "Type 2 diabetes mellitus with hyperglycemia.",
        "symptom_text": "The patient has a history of type 2 diabetes mellitus.The patient reports increased thirst, frequent urination, and unexplained weight loss.Fasting blood glucose level: 200 mg/dL. HbA1c: 8.5%.Type 2 diabetes mellitus with hyperglycemia.The patient presents with classic symptoms of hyperglycemia and has uncontrolled blood glucose levels. No signs of complications such as neuropathy or peripheral angiopathy.Initiated metformin 1000mg once daily, advised dietary modifications, and scheduled follow-up in two weeks for glycemic control monitoring.55FemaleCaucasian"
    },
    "5637": {
        "explanation_text": "Type 2 diabetes mellitus with unspecified complications.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus without any specified complications.The patient presents with polyuria, polydipsia, and unexplained weight loss.Fasting blood glucose level of 180 mg/dL, HbA1c of 8.5%, and no evidence of diabetic neuropathy or peripheral angiopathy on nerve conduction studies and vascular Doppler ultrasound.Type 2 diabetes mellitus with unspecified complications. The patient has Type 2 diabetes mellitus without any specified complications.The patient's blood pressure is within normal limits, and there are no signs of diabetic retinopathy on fundoscopic examination. The patient denies any history of foot ulcers or skin complications.Initiated on metformin 1000mg twice daily, lifestyle modifications, and scheduled for diabetic education.The patient responded well to treatment and education. Discharged home with a follow-up appointment in two weeks.55FemaleCaucasian"
    },
    "5638": {
        "explanation_text": "Type 2 diabetes mellitus without complications.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus without any complications.The patient reports mild polyuria and polydipsia without any signs of neuropathy, foot ulcers, skin ulcers, circulatory problems, hypoglycemia, or hyperglycemia.Fasting blood glucose levels are slightly elevated at 140 mg/dL, HbA1c is 6.8%, and there are no abnormalities in the comprehensive metabolic panel.Type 2 diabetes mellitus without complications. Verbatim EHR quote justifying the code: 'The patient presents with a history of Type 2 diabetes mellitus without any associated complications.'The physician notes the stable condition of the patient with well-controlled blood glucose levels and the absence of any diabetic complications.The patient is advised to continue metformin 1000 mg twice daily, follow a balanced diet, exercise regularly, and monitor blood glucose levels at home.55FemaleCaucasian"
    },
    "5639": {
        "explanation_text": "Other specified diabetes mellitus with hypoglycemia without coma.",
        "symptom_text": "The patient has a history of type 2 diabetes mellitus managed with oral antidiabetic medication. There is no history of foot ulcers, skin complications, or ketoacidosis.The patient presented with symptoms of sweating, confusion, and dizziness, suggestive of hypoglycemia.Laboratory tests indicated low blood glucose levels of 55 mg/dL.Other specified diabetes mellitus with hypoglycemia without coma. The patient's diabetes is complicated by hypoglycemia, leading to the current presentation of sweating, confusion, and dizziness.The patient responded well to the administration of intravenous dextrose and was closely monitored until symptoms resolved.Treatment included intravenous dextrose administration, frequent blood glucose monitoring, and patient education on hypoglycemia management.The patient's symptoms of hypoglycemia resolved, and blood glucose levels stabilized within the normal range. Discharged in stable condition with instructions for glucose monitoring and dietary management.55FemaleCaucasian"
    },
    "5640": {
        "explanation_text": "Other specified diabetes mellitus with hyperglycemia.",
        "symptom_text": "The patient has a history of hypertension and obesity.The patient presents with polyuria, polydipsia, and unexplained weight loss.Fasting blood glucose level of 220 mg/dL and HbA1c of 9.5%.Other specified diabetes mellitus with hyperglycemia (E13.65)The patient's symptoms, along with the elevated fasting blood glucose and HbA1c levels, support the diagnosis of Other specified diabetes mellitus with hyperglycemia.Initiated treatment with metformin, lifestyle modifications, and scheduled follow-up for diabetes education.The patient was discharged in stable condition with improved blood glucose levels and advised to continue the prescribed treatment plan.55FemaleCaucasian"
    },
    "5641": {
        "explanation_text": "Other specified diabetes mellitus without complications.",
        "symptom_text": "The patient has a history of obesity and a sedentary lifestyle, predisposing factors for diabetes mellitus.The patient reports increased thirst and frequent urination, classic symptoms of diabetes mellitus. No symptoms of skin complications, hypoglycemia, or other specific complications are present.Fasting blood glucose levels are elevated at 180 mg/dL. HbA1c level is 7.2%, indicating poorly controlled diabetes.Other specified diabetes mellitus without complications, E139: Other specified diabetes mellitus without complicationsPatient presents with classic symptoms of diabetes mellitus without any signs of complications. Physical examination reveals no skin abnormalities or signs of hypoglycemia.Initiated on metformin 1000mg twice daily, advised on lifestyle modifications including diet and exercise.Patient responded well to treatment and education. Discharged with a scheduled follow-up in 3 weeks.55FemaleCaucasian"
    },
    "5642": {
        "explanation_text": "Increased secretion of gastrin.",
        "symptom_text": "The patient has a history of chronic gastritis and peptic ulcers.The patient presents with recurrent abdominal pain, nausea, and vomiting.Serum gastrin levels are markedly elevated at 500 pg/mL (normal range: 0-100 pg/mL). Gastric pH testing shows pH < 2, indicating increased gastric acid secretion.Increased secretion of gastrin (ICD-10-CM code E164): The patient presents with elevated serum gastrin levels and gastric pH < 2, consistent with increased gastrin secretion.The patient reports worsening abdominal pain after meals and has a history of recurrent peptic ulcers. Physical examination reveals epigastric tenderness.Treatment includes proton pump inhibitors to reduce gastric acid secretion and antibiotics for Helicobacter pylori eradication.The patient responded well to treatment and was discharged with instructions for follow-up serum gastrin level monitoring in three months.56FemaleCaucasian"
    },
    "5643": {
        "explanation_text": "Hypoparathyroidism, unspecified.",
        "symptom_text": "The patient has a history of chronic kidney disease stage 3 due to hypertension. No history of diabetes mellitus or other endocrine disorders.The patient presents with muscle cramps, tingling sensations in the extremities, and fatigue.Laboratory results show low serum calcium levels and elevated serum phosphate levels. Vitamin D levels are within normal limits.Hypoparathyroidism, unspecified: The patient presents with low serum calcium levels, elevated serum phosphate levels, muscle cramps, tingling sensations, and fatigue, consistent with hypoparathyroidism. No findings suggestive of other specified diabetes mellitus, hyperglycemia, or hyperparathyroidism.The patient's symptoms and laboratory findings are indicative of hypoparathyroidism. No signs of diabetic complications or hyperglycemia are present.The patient is started on oral calcium supplements and active vitamin D analogs. Close monitoring of serum calcium and phosphate levels is advised.The patient responded well to treatment and showed improvement in symptoms. Discharged with a follow-up appointment in two weeks for further evaluation.56FemaleCaucasian"
    },
    "5644": {
        "explanation_text": "Primary hyperparathyroidism.",
        "symptom_text": "The patient has a history of recurrent kidney stones and complains of bone pain.The patient presents with fatigue, weakness, and constipation.Lab results show elevated serum calcium levels, low phosphorus levels, and increased parathyroid hormone levels.Primary hyperparathyroidism (ICD-10-CM code E210): Primary hyperparathyroidism is a condition of excessive parathyroid hormone secretion leading to hypercalcemia, low phosphorus levels, and possible bone pain or kidney stones.Patient shows classic signs of primary hyperparathyroidism with elevated calcium and parathyroid hormone levels. Treatment plan includes monitoring calcium levels and considering surgical intervention.Prescribed calcimimetics to lower calcium levels and advised increased fluid intake to prevent kidney stone formation.Patient discharged in stable condition with follow-up scheduled for monitoring calcium levels and symptom management.55FemaleCaucasian"
    },
    "5645": {
        "explanation_text": "Secondary hyperparathyroidism, not elsewhere classified.",
        "symptom_text": "The patient has a history of chronic kidney disease stage 3 due to hypertension.The patient complains of bone pain, muscle weakness, and fatigue.Lab results show elevated parathyroid hormone levels, low serum calcium levels, and high serum phosphate levels.Secondary hyperparathyroidism, not elsewhere classified.The patient's symptoms and lab results are consistent with secondary hyperparathyroidism. No evidence of parathyroid adenomas or hypercalcemia.Treatment with calcimimetics initiated to manage hyperparathyroidism.Patient discharged in stable condition with scheduled follow-up for monitoring parathyroid hormone levels.58FemaleCaucasian"
    },
    "5646": {
        "explanation_text": "Other hyperparathyroidism.",
        "symptom_text": "The patient has a history of chronic kidney disease, which is a known risk factor for hyperparathyroidism. No history of diabetes, hypoparathyroidism, or pituitary disorders.The patient presents with bone pain, fatigue, and muscle weakness, classic symptoms of hyperparathyroidism. No symptoms of hypoglycemia, acromegaly, or inappropriate antidiuretic hormone secretion.Laboratory tests show elevated serum calcium levels and high parathyroid hormone levels, confirming the diagnosis of hyperparathyroidism. No evidence of hypoglycemia, gastrinoma, or pituitary hormone abnormalities.Other hyperparathyroidism (ICD-10-CM code E212): 'Other hyperparathyroidism' specifically refers to cases where the hyperparathyroidism does not fit the criteria for primary or secondary hyperparathyroidism. This code accurately reflects the patient's condition with elevated serum calcium and parathyroid hormone levels.'The endocrinologist notes the presence of classic symptoms of hyperparathyroidism along with confirmatory lab results showing elevated calcium and parathyroid hormone levels. No signs of hypoglycemia, pituitary disorders, or other endocrine abnormalities.The patient was started on hydration therapy and calcimimetic agents to manage hypercalcemia. Close monitoring of calcium levels and renal function was initiated. No treatment for hypoglycemia, pituitary disorders, or diabetes was administered.The patient responded well to treatment, with symptomatic improvement and normalization of calcium levels. Discharged home with instructions for follow-up monitoring of calcium and parathyroid hormone levels. No complications noted during the hospital stay.58FemaleCaucasian"
    },
    "5647": {
        "explanation_text": "Acromegaly and pituitary gigantism.",
        "symptom_text": "The patient, a 45-year-old male of Caucasian descent, has a history of gradually increasing hand and foot size over the past 5 years.The patient reports progressive enlargement of hands and feet, thickening of facial features, joint pain, fatigue, excessive sweating, and headaches.Laboratory tests revealed elevated levels of insulin-like growth factor 1 (IGF-1) and failure to suppress growth hormone levels during an oral glucose tolerance test (OGTT). MRI of the brain showed a pituitary adenoma.Acromegaly and pituitary gigantism - The patient presents with acral enlargement, organomegaly, and characteristic facial features. Laboratory tests showed elevated IGF-1 levels and failure to suppress growth hormone during an OGTT. MRI revealed a pituitary adenoma.The patient's physical examination is consistent with acromegaly and pituitary gigantism. Visual field testing indicated bitemporal hemianopsia, a common finding in patients with pituitary adenomas.The patient underwent transsphenoidal surgery to remove the pituitary adenoma. Postoperatively, the patient was started on somatostatin analog therapy.The patient had an uneventful postoperative course and was discharged with close follow-up for monitoring hormone levels and tumor recurrence.45MaleCaucasian"
    },
    "5648": {
        "explanation_text": "Syndrome of inappropriate secretion of antidiuretic hormone.",
        "symptom_text": "The patient has a history of hypertension and has been taking medication for it for the past five years. There is no history of diabetes, pituitary disorders, or adrenal disorders.The patient presented with nausea, vomiting, confusion, and seizures.Laboratory tests revealed hyponatremia, serum hypo-osmolality, and high urine osmolality. MRI of the brain showed no abnormalities.Syndrome of inappropriate secretion of antidiuretic hormone (ICD-10-CM code E222): The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a condition characterized by the excessive release of antidiuretic hormone (ADH) from the pituitary gland or non-pituitary sources. This results in water retention, dilutional hyponatremia, and impaired water excretion, leading to hyponatremia and hypo-osmolality.The patient's symptoms, along with the laboratory findings of hyponatremia, hypo-osmolality, and high urine osmolality, are consistent with Syndrome of inappropriate secretion of antidiuretic hormone (SIADH). The absence of findings suggestive of other endocrine disorders, such as hyperparathyroidism, pituitary disorders, or adrenal disorders, supports the diagnosis of SIADH.The patient was treated with fluid restriction and hypertonic saline to correct hyponatremia. Monitoring of fluid intake and output was initiated to manage the syndrome effectively.The patient responded well to treatment and showed improvement in symptoms. Discharge instructions include continued fluid restriction and follow-up with the endocrinologist in two weeks.65FemaleCaucasian"
    },
    "5649": {
        "explanation_text": "Hypopituitarism.",
        "symptom_text": "The patient has a history of pituitary adenoma resection.The patient presents with fatigue, weight loss, and hypotension.Lab results indicate low levels of cortisol, thyroid-stimulating hormone, and growth hormone.Hypopituitarism (E230): Decreased secretion of pituitary hormones.The patient's symptoms and lab results are consistent with hypopituitarism following pituitary adenoma resection.Initiated hormone replacement therapy with hydrocortisone, levothyroxine, and growth hormone.The patient responded well to treatment and was discharged with a follow-up scheduled in one month.45FemaleCaucasian"
    },
    "5650": {
        "explanation_text": "Diabetes insipidus.",
        "symptom_text": "The patient has a history of excessive thirst and urination over the past few weeks, leading to dehydration and electrolyte imbalances.The patient presents with polyuria (excessive urination) and polydipsia (excessive thirst). No symptoms of muscle weakness, tingling sensations, or seizures are reported.Lab results show low urine osmolality, high serum osmolality, and normal serum sodium levels. The water deprivation test confirmed the diagnosis of Diabetes insipidus.Diabetes insipidus (E232): The patient presents with polyuria, polydipsia, low urine osmolality, high serum osmolality, and normal serum sodium levels, consistent with the diagnosis of Diabetes insipidus.The endocrinologist evaluated the patient and confirmed the diagnosis of Diabetes insipidus based on the clinical presentation and diagnostic test results. Treatment with desmopressin was initiated.The patient was started on desmopressin to manage the symptoms of Diabetes insipidus and was educated on fluid intake regulation.The patient responded well to treatment with desmopressin, showing a significant reduction in polyuria and polydipsia. The patient was discharged with a follow-up appointment scheduled in two weeks.45FemaleCaucasian"
    },
    "5651": {
        "explanation_text": "Other disorders of pituitary gland.",
        "symptom_text": "The patient has a history of chronic headaches, visual disturbances, and fatigue over the past six months.The patient presents with persistent headaches, visual field deficits, and symptoms of hormone imbalance such as weight gain, irregular menstrual cycles, and cold intolerance.MRI of the brain revealed a pituitary macroadenoma measuring 1.5 cm in diameter compressing the optic chiasm.Other disorders of pituitary gland (ICD-10-CM code E236): Pituitary macroadenoma causing hormonal imbalance and visual disturbances.The patient's symptoms and MRI findings are consistent with a pituitary macroadenoma, leading to the diagnosis of Other disorders of pituitary gland (E236).The patient was started on cabergoline to reduce the size of the pituitary tumor and manage hormone levels. Regular follow-ups with endocrinology are scheduled.The patient responded well to treatment, with a reduction in headaches and improvement in hormonal symptoms. Discharged with instructions for follow-up imaging and endocrine evaluations.42FemaleCaucasian"
    },
    "5652": {
        "explanation_text": "Disorder of pituitary gland, unspecified.",
        "symptom_text": "The patient has a history of chronic headaches and visual disturbances.The patient complains of persistent headaches, visual changes, and fatigue.MRI of the brain revealed a pituitary mass.Disorder of pituitary gland, unspecified (ICD-10-CM code E237)The patient presents with classic symptoms of a pituitary mass, including headaches and visual disturbances. MRI confirmed the presence of a pituitary lesion.The patient was started on hormone replacement therapy and scheduled for transsphenoidal surgery to remove the pituitary mass.The patient underwent successful transsphenoidal surgery without complications and was discharged with close follow-up for hormone level monitoring.45FemaleCaucasian"
    },
    "5653": {
        "explanation_text": "Drug-induced Cushing's syndrome.",
        "symptom_text": "The patient has a history of rheumatoid arthritis and has been on long-term prednisone therapy for the past 6 months.The patient presents with central obesity, moon face, easy bruising, and muscle weakness.Laboratory tests revealed elevated cortisol levels and a positive dexamethasone suppression test.Drug-induced Cushing's syndrome due to prolonged corticosteroid therapy. The patient's symptoms and test results are consistent with this diagnosis.The patient's symptoms have improved upon tapering and discontinuation of prednisone therapy. Follow-up cortisol levels are within normal limits.The patient was advised to discontinue prednisone gradually under medical supervision. Physical therapy was recommended to address muscle weakness.The patient responded well to the treatment plan and was discharged in stable condition.55FemaleCaucasian"
    },
    "5654": {
        "explanation_text": "Cushing's syndrome, unspecified.",
        "symptom_text": "The patient has a history of uncontrolled hypertension and unexplained weight gain over the past six months.The patient presents with central obesity, moon facies, buffalo hump, easy bruising, and muscle weakness.Laboratory tests reveal elevated cortisol levels on multiple occasions, lack of suppression on low-dose dexamethasone suppression test, and absence of adrenal masses on abdominal CT scan.Cushing's syndrome, unspecified. Verbatim EHR quote justifying the code: 'The patient presents with classic signs of Cushing's syndrome, including central obesity, moon facies, buffalo hump, easy bruising, and muscle weakness. Laboratory tests confirm elevated cortisol levels and lack of suppression on dexamethasone suppression test.'The endocrinologist noted the typical physical features of Cushing's syndrome during the examination and ordered further tests to confirm the diagnosis.The patient was started on oral ketoconazole to manage cortisol levels and advised on lifestyle modifications.The patient responded well to treatment, and cortisol levels showed improvement. Discharged with a follow-up appointment in three weeks.45FemaleCaucasian"
    },
    "5655": {
        "explanation_text": "Other primary hyperaldosteronism.",
        "symptom_text": "The patient has a history of hypertension that has been difficult to control despite multiple antihypertensive medications.The patient presents with uncontrolled hypertension, hypokalemia, and metabolic alkalosis.Laboratory tests show low potassium levels and high aldosterone-renin ratio.Other primary hyperaldosteronism (ICD-10-CM code E2609)The patient's symptoms, along with the lab results indicating low potassium and high aldosterone-renin ratio, are consistent with a diagnosis of Other primary hyperaldosteronism.The patient has been started on spironolactone to manage the hyperaldosteronism and normalize potassium levels.The patient's condition improved with treatment, and blood pressure and potassium levels are now within normal limits. The patient is discharged with a follow-up appointment in two weeks.56FemaleCaucasian"
    },
    "5656": {
        "explanation_text": "Hyperaldosteronism, unspecified.",
        "symptom_text": "The patient has a history of hypertension managed with antihypertensive medication.The patient presents with uncontrolled hypertension and occasional muscle weakness.Lab results show elevated aldosterone levels and low renin levels, consistent with hyperaldosteronism.Hyperaldosteronism, unspecified. Verbatim EHR quote justifying the code: 'Lab results show elevated aldosterone levels and low renin levels, consistent with hyperaldosteronism.'Patient's blood pressure is difficult to control despite optimal medical therapy for essential hypertension. The patient does not exhibit signs of adrenal insufficiency such as weakness, fatigue, or weight loss.Prescribed spironolactone to manage hyperaldosteronism and control blood pressure.Patient responded well to treatment with improved blood pressure control. Discharged with a follow-up appointment in one month.54FemaleCaucasian"
    },
    "5657": {
        "explanation_text": "Primary adrenocortical insufficiency.",
        "symptom_text": "The patient has a history of autoimmune disorders and chronic fatigue.The patient presents with fatigue, weight loss, and hypotension.Laboratory tests show low cortisol levels and elevated ACTH levels.Primary adrenocortical insufficiency (E271): The patient presents with fatigue, weight loss, and hypotension. Laboratory tests reveal low cortisol levels and elevated ACTH levels.The patient shows classic symptoms of adrenal insufficiency with low cortisol and high ACTH levels. Treatment with corticosteroid replacement therapy has been initiated.The patient is started on hydrocortisone replacement therapy.The patient responded well to treatment and is stable for discharge.45FemaleCaucasian"
    },
    "5658": {
        "explanation_text": "Addisonian crisis.",
        "symptom_text": "The patient has a known history of primary adrenocortical insufficiency (Addison's disease) and is non-compliant with their glucocorticoid replacement therapy.The patient presents with severe fatigue, abdominal pain, nausea, vomiting, and confusion.Laboratory tests reveal elevated plasma ACTH levels and low cortisol levels. Electrolyte panel shows hyperkalemia and hyponatremia.Addisonian crisis: Acute adrenal insufficiency resulting in hypotension, electrolyte imbalances, and altered mental status.The patient's presentation is consistent with an acute adrenal crisis. Treatment with intravenous hydrocortisone and fluid resuscitation was promptly initiated.The patient received intravenous hydrocortisone for adrenal crisis management along with correction of electrolyte imbalances.The patient responded well to treatment and was discharged with instructions to adhere strictly to their glucocorticoid replacement therapy regimen.45FemaleCaucasian"
    },
    "5659": {
        "explanation_text": "Drug-induced adrenocortical insufficiency.",
        "symptom_text": "The patient has a history of chronic obstructive pulmonary disease (COPD) and has been on long-term corticosteroid therapy for the past 5 years due to severe asthma exacerbations.The patient presents with fatigue, weight loss, hypotension, and skin hyperpigmentation.ACTH stimulation test results indicate a blunted cortisol response, confirming adrenocortical insufficiency induced by corticosteroid therapy.Drug-induced adrenocortical insufficiency due to long-term corticosteroid therapy.The patient's symptoms and diagnostic test results are consistent with drug-induced adrenocortical insufficiency secondary to corticosteroid use.Discontinuation of corticosteroid therapy and initiation of hydrocortisone replacement therapy.The patient was stabilized on hydrocortisone replacement therapy and educated on the importance of regular follow-ups for monitoring cortisol levels and adjusting the dosage as needed.58MaleCaucasian"
    },
    "5660": {
        "explanation_text": "Unspecified adrenocortical insufficiency.",
        "symptom_text": "The patient has a history of fatigue, weight loss, and hypotension over the last few months.The patient presents with fatigue, weight loss, hypotension, and hyperpigmentation of the skin.Laboratory tests show low cortisol levels and elevated ACTH levels.Unspecified adrenocortical insufficiency (ICD-10-CM code E2740): The term 'adrenocortical insufficiency' is used when there is decreased production of adrenal cortex hormones. The unspecified nature of this code fits when the specific cause or type of insufficiency is not documented.The patient reports feeling extremely fatigued and has been experiencing dizziness upon standing. Physical examination reveals hyperpigmentation of the skin, especially in skin folds and scars.The patient is started on hydrocortisone replacement therapy to manage the adrenocortical insufficiency.The patient responded well to treatment and is advised to follow up with an endocrinologist for long-term management of their condition.45FemaleCaucasian"
    },
    "5661": {
        "explanation_text": "Other adrenocortical insufficiency.",
        "symptom_text": "The patient has a history of autoimmune disorders and has been previously diagnosed with autoimmune thyroiditis.The patient presents with fatigue, weight loss, and generalized weakness.Laboratory tests show low cortisol levels and elevated adrenocorticotropic hormone (ACTH) levels.Other adrenocortical insufficiency (ICD-10-CM code E2749): The patient presents with fatigue, weight loss, and generalized weakness. Laboratory tests reveal low cortisol levels and elevated adrenocorticotropic hormone (ACTH) levels.The patient's symptoms and lab results are consistent with a diagnosis of Other adrenocortical insufficiency. No signs of hyperpigmentation or electrolyte imbalances are noted.Treatment includes hormone replacement therapy with glucocorticoids.The patient responded well to treatment and is advised to follow up with endocrinology for further management.45FemaleCaucasian"
    },
    "5662": {
        "explanation_text": "Disorder of adrenal gland, unspecified.",
        "symptom_text": "The patient has a history of hypertension and obesity.The patient presents with fatigue, muscle weakness, and unexplained weight loss.Laboratory tests show elevated potassium levels and low sodium levels.Disorder of adrenal gland, unspecified: The patient presents with fatigue, muscle weakness, and unexplained weight loss, along with laboratory tests showing elevated potassium levels and low sodium levels.The patient's symptoms and lab results are consistent with an unspecified disorder of the adrenal gland. No specific findings to suggest a different adrenal gland disorder.Treatment includes hormone replacement therapy and dietary modifications.The patient responded well to treatment and was discharged in stable condition.55FemaleCaucasian"
    },
    "5663": {
        "explanation_text": "Polycystic ovarian syndrome.",
        "symptom_text": "The patient, a 28-year-old female, presents with a history of irregular menstrual cycles since adolescence and concerns about excessive hair growth on her face and body.The patient reports irregular periods occurring every 35-45 days, hirsutism with coarse hair growth on the upper lip, chin, and lower abdomen, and occasional acne outbreaks.Laboratory tests revealed elevated levels of androgens, including testosterone and DHEA-S. An ultrasound of the pelvis showed enlarged ovaries with multiple small follicles at the periphery, confirming the diagnosis of Polycystic ovarian syndrome.Polycystic ovarian syndrome (E282): The patient presents with irregular periods, hirsutism, elevated androgens, and ultrasound findings of polycystic ovaries, meeting the diagnostic criteria for Polycystic ovarian syndrome.The patient's symptoms align with the Rotterdam criteria for diagnosing Polycystic ovarian syndrome, including both clinical and biochemical features. No signs of other endocrine disorders or adrenal abnormalities were noted.Treatment includes oral contraceptives to regulate menstrual cycles, anti-androgen medications to manage hirsutism, and lifestyle modifications focusing on diet and exercise to improve insulin sensitivity.The patient responded well to treatment and was discharged with a follow-up appointment in 3 months to monitor symptom improvement and adjust the treatment plan if needed.28FemaleNot specified"
    },
    "5664": {
        "explanation_text": "Other primary ovarian failure.",
        "symptom_text": "The patient has a history of irregular menstrual cycles and difficulty conceiving for the past two years.The patient presents with irregular menstruation, hot flashes, night sweats, and infertility.Lab results indicate low estrogen and inhibin levels with elevated FSH levels. Pelvic ultrasound shows normal ovaries without cysts.Other primary ovarian failure (E2839): The patient presents with irregular menstruation, infertility, and elevated FSH levels, indicative of ovarian dysfunction without other specified ovarian disorders.The patient reports a two-year history of infertility and irregular menstrual cycles. Lab results confirm low estrogen and inhibin levels with high FSH levels, consistent with ovarian failure. Imaging studies show normal ovaries without cysts.Initiated hormone replacement therapy to manage symptoms and improve hormonal balance. Recommended follow-up in three months for reevaluation.32FemaleCaucasian"
    },
    "5665": {
        "explanation_text": "Testicular hypofunction.",
        "symptom_text": "The patient has a history of testicular trauma during childhood.The patient presents with decreased libido, erectile dysfunction, fatigue, and infertility.Hormone panel results show low levels of testosterone and elevated levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Testicular ultrasound reveals small testicular size.Testicular hypofunction: The patient presents with decreased libido, erectile dysfunction, fatigue, and infertility. Hormone panel results show low levels of testosterone and elevated levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Testicular ultrasound reveals small testicular size.The patient reports a significant impact on his quality of life due to the symptoms. Physical examination shows small testicular size consistent with testicular hypofunction. The diagnostic tests confirm the presence of primary testicular failure.The patient will be started on testosterone replacement therapy to address the hormonal imbalance and improve symptoms. Follow-up hormone panels will be scheduled to monitor treatment efficacy.The patient responded well to treatment with improved libido and energy levels. He will continue testosterone replacement therapy as an outpatient.38MaleCaucasian"
    },
    "5666": {
        "explanation_text": "Unspecified severe protein-calorie malnutrition.",
        "symptom_text": "The patient has a history of chronic undernutrition due to financial constraints and limited access to food.The patient presents with severe muscle wasting, generalized edema, and significant weight loss.Laboratory tests show extremely low serum albumin and total protein levels, confirming severe protein-calorie malnutrition.Unspecified severe protein-calorie malnutrition (ICD-10-CM code E43): The patient presents with severe muscle wasting, generalized edema, and significant weight loss, along with extremely low serum albumin and total protein levels, confirming severe protein-calorie malnutrition.The patient's malnutrition is severe, requiring immediate intervention to prevent further complications.The patient is started on a high-protein diet, nutritional supplements, and close monitoring by the dietitian and healthcare team.The patient's condition has improved with nutritional support, and arrangements have been made for ongoing dietary counseling and support post-discharge.45FemaleCaucasian"
    },
    "5667": {
        "explanation_text": "Vitamin A deficiency, unspecified.",
        "symptom_text": "The patient has a history of a diet lacking in Vitamin A-rich foods and has not been taking any Vitamin A supplements.The patient presents with night blindness, dry eyes, and increased susceptibility to infections.Laboratory tests reveal low serum retinol levels consistent with Vitamin A deficiency.Vitamin A deficiency, unspecified. Verbatim EHR quote justifying the code: 'Patient presents with symptoms of night blindness, dry eyes, and low serum retinol levels, indicative of Vitamin A deficiency.'The physician noted the classic signs of Vitamin A deficiency in the patient and recommended immediate intervention.The patient was started on Vitamin A supplements and advised to incorporate Vitamin A-rich foods into their diet.The patient responded well to treatment and was discharged with a plan for follow-up to monitor Vitamin A levels and symptom improvement.45FemaleCaucasian"
    },
    "5668": {
        "explanation_text": "Wernicke's encephalopathy.",
        "symptom_text": "The patient has a history of chronic alcohol misuse.The patient presents with ataxia, ophthalmoplegia, confusion, nystagmus, and memory problems.Thiamine levels are significantly low.Wernicke's encephalopathy. Verbatim: 'Patient diagnosed with Wernicke's encephalopathy based on the classic triad of symptoms (ataxia, ophthalmoplegia, confusion), along with nystagmus, abnormal eye movements, and low thiamine levels.'The patient shows the classic signs of Wernicke's encephalopathy, and the diagnosis is supported by the low thiamine levels.Immediate thiamine replacement therapy initiated.The patient responded well to thiamine replacement therapy and was discharged with a recommendation for continued abstinence from alcohol.52MaleCaucasian"
    },
    "5669": {
        "explanation_text": "Thiamine deficiency, unspecified.",
        "symptom_text": "The patient has a history of poor diet lacking in essential vitamins and minerals due to financial constraints.The patient presents with confusion, muscle weakness, and peripheral neuropathy.Thiamine levels were significantly low in the blood test.Thiamine deficiency, unspecified. Verbatim EHR quote justifying the code: 'The patient's symptoms of confusion, muscle weakness, and peripheral neuropathy, along with significantly low thiamine levels in the blood test, are indicative of thiamine deficiency.'The patient's symptoms improved significantly with thiamine supplementation.The patient was treated with thiamine supplements and dietary counseling.The patient's symptoms resolved, and they were discharged with instructions to maintain a balanced diet rich in essential vitamins and minerals.45FemaleCaucasian"
    },
    "5670": {
        "explanation_text": "Deficiency of other specified B group vitamins.",
        "symptom_text": "The patient has a history of a diet lacking in specific B group vitamins due to poor dietary habits.The patient presents with fatigue, weakness, glossitis, and angular stomatitis.Laboratory tests revealed low levels of specific B group vitamins in the patient's bloodwork.Deficiency of other specified B group vitamins (E538): The patient has a documented history of a diet lacking in specific B group vitamins due to poor dietary habits, presenting with fatigue, weakness, glossitis, and angular stomatitis.The patient's symptoms and lab results are consistent with a deficiency of other specified B group vitamins, likely due to inadequate dietary intake.The patient was started on oral vitamin B complex supplements and referred to a dietitian for nutritional counseling.The patient responded well to treatment and was discharged with instructions to continue the prescribed supplements and follow up with the dietitian.45FemaleCaucasian"
    },
    "5671": {
        "explanation_text": "Vitamin B deficiency, unspecified.",
        "symptom_text": "The patient has a history of a poor diet lacking in Vitamin B-rich foods and has not been taking any Vitamin B supplements.The patient presents with fatigue, weakness, glossitis, and shortness of breath upon exertion.Laboratory tests show decreased levels of Vitamin B in the blood and macrocytic anemia.Vitamin B deficiency, unspecified (E539): The patient presents with fatigue, weakness, glossitis, and macrocytic anemia, along with low levels of Vitamin B in the blood.The patient reports a recent onset of symptoms, correlating with the laboratory findings of low Vitamin B levels. The physical examination reveals pallor and a beefy, red tongue consistent with glossitis.The patient is prescribed Vitamin B complex supplements and advised to incorporate Vitamin B-rich foods into their diet.The patient responded well to treatment and showed improvement in symptoms. Discharge instructions include continuing the Vitamin B supplements and following up with a primary care physician for further monitoring.45FemaleCaucasian"
    },
    "5672": {
        "explanation_text": "Vitamin D deficiency, unspecified.",
        "symptom_text": "The patient has a history of lactose intolerance but has been managing it with dietary modifications.The patient presents with diffuse bone pain, muscle weakness, and generalized fatigue.Laboratory tests reveal low serum levels of 25-hydroxyvitamin D.Vitamin D deficiency, unspecifiedThe patient reports increased generalized pain and fatigue over the last few months. Physical examination shows diffuse tenderness over bony prominences. Laboratory results confirm low serum Vitamin D levels.The patient is advised to take Vitamin D supplements and increase sun exposure. Follow-up blood tests are scheduled to monitor Vitamin D levels.The patient responded well to treatment and is advised to continue with Vitamin D supplements and follow-up as scheduled.45FemaleCaucasian"
    },
    "5673": {
        "explanation_text": "Vitamin deficiency, unspecified.",
        "symptom_text": "The patient has a history of a balanced diet without any known dietary restrictions. No history of malabsorption syndromes or bariatric surgery.The patient presents with fatigue, muscle weakness, and pale skin.Laboratory tests reveal low levels of multiple vitamins without any specific deficiencies identified.Vitamin deficiency, unspecifiedThe patient's symptoms and lab results are consistent with a general vitamin deficiency. No specific findings point towards a particular vitamin deficiency or other nutritional issues.The patient was prescribed a daily multivitamin supplement and advised to follow a balanced diet rich in fruits and vegetables.The patient responded well to treatment and was discharged with recommendations for follow-up blood tests in three months to monitor vitamin levels.45FemaleCaucasian"
    },
    "5674": {
        "explanation_text": "Dietary zinc deficiency.",
        "symptom_text": "The patient has a history of a diet low in zinc-rich foods such as meat, nuts, and seeds.The patient presents with poor wound healing and growth retardation.Laboratory tests reveal low serum zinc levels of 50 mcg/dL (normal range: 70-120 mcg/dL).Dietary zinc deficiencyThe patient's symptoms and lab results are consistent with a diagnosis of Dietary zinc deficiency. Initiating zinc supplementation.Prescribed oral zinc supplements and dietary counseling to increase zinc intake.The patient responded well to treatment and is advised to continue zinc supplementation and follow up with a nutritionist for dietary guidance.45FemaleCaucasian"
    },
    "5675": {
        "explanation_text": "Magnesium deficiency.",
        "symptom_text": "The patient has a history of poor dietary intake and chronic alcoholism, which are risk factors for magnesium deficiency.The patient presents with muscle weakness, tremors, and cardiac arrhythmias, all of which are consistent with magnesium deficiency.Serum magnesium levels are significantly low at 1.2 mg/dL (normal range: 1.7-2.2 mg/dL). Other electrolyte levels are within normal limits.Magnesium deficiency (ICD-10-CM code E612) - Verbatim EHR quote justifying the code: 'Serum magnesium levels are significantly low at 1.2 mg/dL.'The patient's symptoms and low serum magnesium levels indicate a clear case of magnesium deficiency. The patient is started on oral magnesium supplements.Treatment includes oral magnesium supplements and dietary counseling to increase magnesium-rich foods intake.The patient's symptoms improved with magnesium supplementation, and serum magnesium levels normalized. The patient is discharged with dietary recommendations and a follow-up appointment in two weeks.55MaleCaucasian"
    },
    "5676": {
        "explanation_text": "Other specified nutritional deficiencies.",
        "symptom_text": "The patient has a history of a strict vegan diet for the past two years.The patient presents with fatigue, muscle weakness, pale skin, and hair loss.Laboratory tests show low serum levels of vitamin B12 and iron.Other specified nutritional deficiencies (ICD-10-CM code E638): The patient presents with fatigue, muscle weakness, pale skin, and hair loss along with low serum levels of vitamin B12 and iron, consistent with a nutritional deficiency.The patient's symptoms and lab results suggest a specific nutritional deficiency, likely due to the strict vegan diet lacking in essential nutrients.The patient was started on vitamin B12 and iron supplements and advised to modify their diet to include sources rich in these nutrients.The patient responded well to treatment and was discharged with a plan for follow-up lab tests to monitor nutrient levels.34FemaleCaucasian"
    },
    "5677": {
        "explanation_text": "Localized adiposity.",
        "symptom_text": "The patient has a history of gradual, localized fat accumulation in the abdominal region over the past few years.The patient reports cosmetic concerns due to the visible excess fat in the abdominal area. No systemic symptoms or signs of nutritional deficiencies are noted.Physical examination reveals a disproportionate increase in subcutaneous fat in the abdominal region with no evidence of generalized obesity. Laboratory tests show normal levels of vitamins and minerals ruling out any deficiencies.Localized adiposity (E65): The patient presents with localized fat accumulation in the abdominal region without evidence of generalized obesity. The excess fat is causing cosmetic concerns for the patient.The patient's condition is consistent with localized adiposity, commonly known as a 'belly fat' issue. No signs of nutritional deficiencies or other systemic diseases are observed.The patient is advised on lifestyle modifications, including dietary changes and targeted exercises to reduce the localized fat in the abdominal area.The patient is discharged with recommendations for regular follow-ups with a nutritionist and a fitness trainer to monitor progress in reducing localized adiposity.42FemaleCaucasian"
    },
    "5678": {
        "explanation_text": "Morbid (severe) obesity due to excess calories.",
        "symptom_text": "The patient has a history of gradual weight gain over the past five years, with a BMI consistently over 40 for the last two years.The patient reports fatigue and shortness of breath upon exertion, which are attributed to the excess weight.Lab results show elevated cholesterol levels and fasting glucose, consistent with obesity-related metabolic changes.Morbid (severe) obesity due to excess calories. Verbatim EHR quote justifying the code: 'Patient presents with a BMI over 40 for the last two years along with symptoms of fatigue and shortness of breath related to excess weight.'The physician notes the need for weight management interventions to reduce the risk of obesity-related complications such as cardiovascular disease and diabetes.The patient is advised on a personalized diet plan and referred to a nutritionist for counseling. A structured exercise program is recommended to aid in weight loss.The patient is discharged with a follow-up appointment in two weeks to monitor progress on the weight management plan.42FemaleCaucasian"
    },
    "5679": {
        "explanation_text": "Other obesity due to excess calories.",
        "symptom_text": "The patient has a history of gradual weight gain over the past five years, with a significant increase in calorie intake due to poor dietary habits.The patient presents with fatigue, shortness of breath on exertion, and joint pain exacerbated by weight-bearing activities.Laboratory tests reveal elevated cholesterol levels and insulin resistance. Imaging studies show excess adipose tissue distribution.Other obesity due to excess calories (E6609): The EHR reflects the patient's history of weight gain, poor dietary habits leading to excess calorie intake, fatigue, shortness of breath, joint pain, elevated cholesterol, insulin resistance, and excess adipose tissue distribution.The physician notes the patient's BMI of 33, central adiposity, and recommends dietary modifications, increased physical activity, and close monitoring of lipid profiles and glucose levels.The patient is advised to follow a balanced low-calorie diet, engage in regular exercise, and prescribed metformin for glycemic control.The patient was discharged with dietary recommendations, exercise guidelines, and a follow-up appointment in three months to assess progress.42FemaleCaucasian"
    },
    "5680": {
        "explanation_text": "Morbid (severe) obesity with alveolar hypoventilation.",
        "symptom_text": "The patient has a history of obesity and has struggled with weight management for several years.The patient presents with extreme weight gain, BMI of 45, daytime drowsiness, morning headaches, and episodes of shallow breathing.ABG results show elevated PaCO2 levels indicating alveolar hypoventilation.Morbid (severe) obesity with alveolar hypoventilationThe patient's BMI classifies as morbidly obese, and ABG results confirm alveolar hypoventilation, supporting the diagnosis of Morbid (severe) obesity with alveolar hypoventilation.The patient was started on continuous positive airway pressure (CPAP) therapy, referred to a nutritionist for weight management, and scheduled for weight loss surgery consultation.The patient responded well to CPAP therapy, showed improvement in symptoms, and was discharged with a follow-up plan for weight loss intervention.42FemaleCaucasian"
    },
    "5681": {
        "explanation_text": "Overweight.",
        "symptom_text": "The patient has a history of being overweight for the past five years, with a gradual increase in weight noted during routine check-ups.The patient presents with fatigue, shortness of breath upon exertion, and joint pain, all of which are commonly associated with being overweight.Lab results indicate elevated BMI (Body Mass Index) of 32, consistent with a diagnosis of overweight. Fasting blood glucose levels are within normal limits ruling out diabetes.Overweight: The patient's medical history, symptoms, and elevated BMI of 32 support the diagnosis of overweight. Verbatim EHR quote justifying the code: 'The patient has a history of being overweight for the past five years, with a gradual increase in weight noted during routine check-ups. Lab results indicate elevated BMI of 32, consistent with a diagnosis of overweight.'The physician notes the importance of lifestyle modifications, including dietary changes and increased physical activity, to manage the patient's weight and reduce associated health risks.The patient is advised to follow a balanced diet plan provided by a nutritionist and start a moderate exercise routine. Follow-up in three months is scheduled to monitor progress.42FemaleCaucasian"
    },
    "5682": {
        "explanation_text": "Albinism, unspecified.",
        "symptom_text": "The patient has a history of visual impairment and photosensitivity since childhood. There is a family history of similar pigmentation issues.The patient presents with white or very light skin, white hair, and light blue eyes. Examination reveals nystagmus and reduced visual acuity.Ophthalmologic exam shows foveal hypoplasia and iris transillumination defects, confirming the diagnosis of Albinism.Albinism, unspecified - The lack of melanin production results in white skin, hair, and light eyes. This is consistent with the clinical findings of foveal hypoplasia and iris transillumination defects.The patient's symptoms and diagnostic test results are indicative of Albinism. Genetic counseling has been recommended for further evaluation and management.The patient is advised on sun protection measures and the use of visual aids to manage the associated vision problems.The patient is stable and discharged with recommendations for regular follow-up with an ophthalmologist and a genetic counselor.32MaleCaucasian"
    },
    "5683": {
        "explanation_text": "Homocystinuria.",
        "symptom_text": "The patient has a known history of Homocystinuria, an autosomal recessive disorder affecting the metabolism of the amino acid methionine.The patient presents with symptoms including ectopia lentis, intellectual disability, skeletal abnormalities, and a history of thromboembolic events.Laboratory tests revealed elevated levels of homocysteine in the blood and increased urine homocysteine excretion.Homocystinuria (E7211): Homocystinuria due to cystathionine beta-synthase deficiencyThe patient's symptoms and diagnostic test results are consistent with a diagnosis of Homocystinuria, specifically caused by cystathionine beta-synthase deficiency.The patient is being treated with a low-methionine diet, vitamin B6 supplementation, and betaine to manage homocysteine levels.The patient's condition has been stabilized, and arrangements have been made for long-term management and follow-up for Homocystinuria.16FemaleCaucasian"
    },
    "5684": {
        "explanation_text": "von Gierke disease.",
        "symptom_text": "The patient has a known history of von Gierke disease, a rare genetic disorder affecting glycogen metabolism.The patient presents with hepatomegaly, growth retardation, fasting hypoglycemia, and elevated liver enzymes.Laboratory tests show severe hypoglycemia, hyperlipidemia, hyperuricemia, and elevated lactate levels.Von Gierke disease (ICD-10-CM code E7401): \"E7401 Glycogen storage disease, type I\"The patient's symptoms and diagnostic results align with a diagnosis of von Gierke disease. The presence of hepatomegaly, fasting hypoglycemia, and elevated liver enzymes is characteristic of this condition.The patient is started on a diet rich in uncooked cornstarch, frequent meals, and monitoring of blood glucose levels. Consultation with a genetic counselor is recommended.The patient's condition improved with dietary modifications and close monitoring. Discharge instructions include dietary restrictions and regular follow-up with the endocrinologist.8 years oldMaleCaucasian"
    },
    "5685": {
        "explanation_text": "Other disorders of intestinal carbohydrate absorption.",
        "symptom_text": "The patient has a history of chronic gastrointestinal discomfort, bloating, and diarrhea after consuming foods high in carbohydrates.The patient presents with chronic diarrhea, foul-smelling stools, abdominal bloating, and occasional flatulence.Laboratory tests show an elevated level of fecal carbohydrates, indicating malabsorption.Other disorders of intestinal carbohydrate absorption (ICD-10-CM code E7439): The patient presents with chronic diarrhea, foul-smelling stools, and bloating after consuming carbohydrates, along with elevated fecal carbohydrates, consistent with a diagnosis of Other disorders of intestinal carbohydrate absorption.The patient reports significant relief of symptoms with a low-carbohydrate diet. Physical examination reveals no signs of malnutrition or other systemic diseases.The patient is advised to follow a low-carbohydrate diet, increase fluid intake, and take probiotics to manage symptoms.The patient responded well to dietary modifications and symptom management. Discharged in stable condition with instructions to follow up with a gastroenterologist if symptoms persist.45FemaleCaucasian"
    },
    "5686": {
        "explanation_text": "Pure hypercholesterolemia, unspecified.",
        "symptom_text": "The patient has a history of mild hypertension controlled with lifestyle modifications.The patient is asymptomatic and denies any chest pain, shortness of breath, or exercise intolerance.Recent lipid panel results show elevated total cholesterol levels of 300 mg/dL with LDL cholesterol levels of 220 mg/dL.Pure hypercholesterolemia, unspecified. Verbatim EHR quote justifying the code: 'Recent lipid panel results show elevated total cholesterol levels of 300 mg/dL with LDL cholesterol levels of 220 mg/dL.'Patient counseled on dietary modifications to reduce cholesterol intake and advised to increase physical activity. Statin therapy initiated with close follow-up scheduled in 3 months.1. Prescribed atorvastatin 20 mg daily. 2. Dietary consultation with a focus on a low-cholesterol diet. 3. Encouraged regular aerobic exercise.55MaleCaucasian"
    },
    "5687": {
        "explanation_text": "Familial hypercholesterolemia.",
        "symptom_text": "The patient has a family history of hypercholesterolemia with multiple family members experiencing premature cardiovascular events.The patient presents with xanthomas on the extensor tendons of both hands.Laboratory results show significantly elevated LDL-C levels of 250 mg/dL.Familial hypercholesterolemia (ICD-10-CM code E7801): The patient presents with xanthomas and significantly elevated LDL-C levels, consistent with a diagnosis of familial hypercholesterolemia.The patient's physical exam revealed xanthomas on the hands, and laboratory tests confirmed markedly elevated LDL-C levels. The family history of hypercholesterolemia and premature cardiovascular events further support the diagnosis of familial hypercholesterolemia.The patient was started on high-intensity statin therapy and advised on lifestyle modifications to manage the hypercholesterolemia.The patient responded well to treatment and was discharged with a plan for close follow-up to monitor lipid levels and cardiovascular risk.45MaleCaucasian"
    },
    "5688": {
        "explanation_text": "Mixed hyperlipidemia.",
        "symptom_text": "The patient has a history of obesity, sedentary lifestyle, and a family history of hyperlipidemia.The patient is asymptomatic and denies any chest pain, shortness of breath, or palpitations.Lipid panel results show elevated total cholesterol, elevated triglycerides, and normal LDL and HDL levels.Mixed hyperlipidemia (E782): The patient presents with elevated total cholesterol and triglyceride levels, meeting the criteria for a diagnosis of Mixed hyperlipidemia.The patient was educated on lifestyle modifications including a heart-healthy diet and regular exercise. Follow-up lipid panels were scheduled.Prescription of atorvastatin 20mg daily to manage the mixed hyperlipidemia.45FemaleCaucasian"
    },
    "5689": {
        "explanation_text": "Hyperuricemia without signs of inflammatory arthritis and tophaceous disease.",
        "symptom_text": "The patient has a history of occasional joint discomfort but no history of gout, tophi, or inflammatory arthritis. No previous diagnoses of metabolic disorders.The patient complains of intermittent joint pain in the absence of swelling, redness, or tophi. Denies any recent trauma or injury.Laboratory tests revealed elevated serum uric acid levels of 8.5 mg/dL (normal range: 2.4-6.0 mg/dL). Renal function tests were within normal limits.Hyperuricemia without signs of inflammatory arthritis and tophaceous disease. The patient presents with elevated serum uric acid levels without evidence of joint inflammation or tophi.Patient denies any recent dietary changes or alcohol consumption. Physical examination shows no signs of joint inflammation or tophi. No skin lesions or nodules noted.Prescribed nonsteroidal anti-inflammatory drugs (NSAIDs) for pain management and advised dietary modifications to reduce purine-rich foods.The patient responded well to treatment with a decrease in joint pain. Scheduled for a follow-up in 4 weeks for reevaluation.56MaleCaucasian"
    },
    "5690": {
        "explanation_text": "Wilson's disease.",
        "symptom_text": "The patient has a known history of Wilson's disease, diagnosed five years ago.The patient presents with fatigue, abdominal pain, jaundice, tremors, and difficulty walking.Serum ceruloplasmin levels are low, and urinary copper excretion is elevated. Abdominal ultrasound shows hepatomegaly with evidence of cirrhosis. Ophthalmologic exam reveals Kayser-Fleischer rings.Wilson's disease (E8301): The patient presents with a known history of Wilson's disease, low serum ceruloplasmin levels, high urinary copper excretion, hepatomegaly with cirrhosis on imaging, and Kayser-Fleischer rings on ophthalmologic exam.The patient's symptoms and diagnostic findings are consistent with the diagnosis of Wilson's disease. Treatment with chelating agents to reduce copper levels and supportive care for liver dysfunction is initiated.The patient is started on oral chelating agents like D-penicillamine to reduce copper accumulation. Additionally, supportive therapy for liver cirrhosis is provided.The patient responded well to treatment and is stable for discharge. Close follow-up with a hepatologist is recommended for ongoing management of Wilson's disease.32FemaleCaucasian"
    },
    "5691": {
        "explanation_text": "Hereditary hemochromatosis.",
        "symptom_text": "The patient has a family history of hereditary hemochromatosis.The patient complains of chronic fatigue, joint pain, and abdominal discomfort.Genetic testing revealed homozygosity for the C282Y mutation, serum ferritin level of 600 ng/mL, and transferrin saturation of 60%.Hereditary hemochromatosis (ICD-10-CM code E83110): Genetic testing confirmed homozygosity for the C282Y mutation, elevated serum ferritin, and transferrin saturation, consistent with hereditary hemochromatosis.The patient presents with classic symptoms of hereditary hemochromatosis and has a positive family history of the condition. Genetic testing results are conclusive for the diagnosis.Phlebotomy sessions scheduled to reduce iron overload, dietary recommendations to limit iron intake, and monitoring of iron levels.Patient discharged in stable condition with a follow-up appointment scheduled for monitoring iron levels and adjusting the treatment plan as needed.45MaleCaucasian"
    },
    "5692": {
        "explanation_text": "Hemochromatosis due to repeated red blood cell transfusions.",
        "symptom_text": "The patient has a history of chronic anemia requiring repeated red blood cell transfusions.The patient presents with fatigue, joint pain, and abdominal discomfort.Laboratory results indicate elevated serum ferritin levels of 800 ng/mL and transferrin saturation of 70%.Hemochromatosis due to repeated red blood cell transfusions. Iron overload leading to tissue damage and organ dysfunction.Patient shows signs of bronze skin pigmentation and hepatomegaly. No evidence of liver cirrhosis or neurological symptoms.Initiated therapeutic phlebotomy to reduce iron levels and advised dietary modifications to limit iron intake.Patient responded well to treatment, with symptoms improving. Scheduled for regular follow-ups to monitor iron levels and organ function.56MaleCaucasian"
    },
    "5693": {
        "explanation_text": "Hemochromatosis, unspecified.",
        "symptom_text": "The patient has a history of chronic fatigue, joint pain, and liver function abnormalities.The patient presents with fatigue, joint pain, and abdominal discomfort.Serum iron levels are markedly elevated, transferrin saturation is above 50%, and liver biopsy shows iron deposition.Hemochromatosis, unspecified (ICD-10-CM code E83119): The patient presents with fatigue, joint pain, and abdominal discomfort. Diagnostic tests reveal markedly elevated serum iron levels, transferrin saturation above 50%, and liver biopsy demonstrating iron deposition.The patient shows classic symptoms of hemochromatosis with confirmatory diagnostic test results indicating iron overload. Differential diagnoses such as hyperlipidemia, hyperuricemia, and other mineral metabolism disorders are not supported by the clinical presentation and test results.Phlebotomy sessions scheduled to reduce iron levels and alleviate symptoms. Dietary recommendations to limit iron intake.The patient responded well to phlebotomy treatments with symptomatic improvement. Discharged with a follow-up plan for continued monitoring of iron levels.52MaleCaucasian"
    },
    "5694": {
        "explanation_text": "Other disorders of iron metabolism.",
        "symptom_text": "The patient has a history of occasional fatigue and weakness, which prompted further evaluation.The patient presented with fatigue, weakness, and pallor. No history of joint pain or swelling.Laboratory tests revealed low hemoglobin levels and elevated serum iron and ferritin levels.Other disorders of iron metabolismThe patient has no signs of hyperlipidemia, hyperuricemia, bilirubin metabolism disorders, Wilson's disease, hemochromatosis, phosphorus metabolism disorders, magnesium or calcium metabolism disorders, cystic fibrosis, or other mineral metabolism disorders.The patient was started on iron chelation therapy and advised dietary modifications.The patient responded well to treatment and was discharged in stable condition.45FemaleCaucasian"
    },
    "5695": {
        "explanation_text": "Other disorders of phosphorus metabolism.",
        "symptom_text": "The patient has a history of chronic kidney disease stage 3 and has been on a low-phosphorus diet for the past two years.The patient presents with muscle weakness, bone pain, and numbness in the extremities.Serum phosphorus levels are significantly low at 1.8 mg/dL (normal range: 2.5-4.5 mg/dL). Calcium and magnesium levels are within normal limits.Other disorders of phosphorus metabolismPatient's symptoms and significantly low serum phosphorus levels indicate a disorder of phosphorus metabolism. The patient's medical history of chronic kidney disease and adherence to a low-phosphorus diet further support this diagnosis.Initiated treatment with phosphorus supplements and scheduled a follow-up to monitor phosphorus levels.The patient's symptoms improved with phosphorus supplementation, and serum phosphorus levels increased to 3.2 mg/dL at discharge.58FemaleCaucasian"
    },
    "5696": {
        "explanation_text": "Hypermagnesemia.",
        "symptom_text": "The patient has a history of chronic kidney disease stage 3 and has been on magnesium-containing supplements for the past year.The patient presents with muscle weakness, lethargy, and nausea.Laboratory results show serum magnesium levels of 3.2 mEq/L (normal range: 1.7-2.3 mEq/L). Creatinine clearance is 45 mL/min.Hypermagnesemia: Elevated serum magnesium levels causing neuromuscular and gastrointestinal symptoms. The patient's serum magnesium level of 3.2 mEq/L is above the normal range, indicating Hypermagnesemia.The patient's symptoms of muscle weakness and lethargy are consistent with Hypermagnesemia. Renal impairment from chronic kidney disease predisposes the patient to magnesium retention and toxicity.Treatment includes intravenous fluids, loop diuretics, and discontinuation of magnesium-containing supplements. Close monitoring of serum magnesium levels is advised.The patient responded well to treatment, and serum magnesium levels normalized. Discharged with recommendations to avoid magnesium-rich foods and supplements.65FemaleCaucasian"
    },
    "5697": {
        "explanation_text": "Hypercalcemia.",
        "symptom_text": "The patient has a history of chronic kidney disease and takes calcium and vitamin D supplements regularly.The patient presented with fatigue, frequent urination, and abdominal pain.Laboratory tests revealed elevated serum calcium levels of 12.5 mg/dL.Hypercalcemia (E8352): Serum calcium level is elevated, consistent with the diagnosis of Hypercalcemia.Patient's symptoms and lab results are indicative of Hypercalcemia. No signs of iron or magnesium disorders were observed.The patient was advised to discontinue calcium and vitamin D supplements. Intravenous fluids were administered to promote calcium excretion.The patient's serum calcium levels returned to normal range, and symptoms resolved. Discharged with instructions to avoid over-the-counter calcium supplements and follow up with the primary care physician in two weeks.55MaleCaucasian"
    },
    "5698": {
        "explanation_text": "Other disorders of calcium metabolism.",
        "symptom_text": "The patient has a history of chronic kidney disease stage 3, which can predispose to calcium metabolism disorders.The patient presents with fatigue, muscle weakness, and frequent bone fractures, suggestive of calcium metabolism abnormalities.Laboratory tests reveal elevated serum calcium levels and decreased parathyroid hormone levels, indicating a disturbance in calcium regulation.Other disorders of calcium metabolismThe patient's symptoms, along with the diagnostic test results, are consistent with Other disorders of calcium metabolism. The elevated serum calcium levels and decreased parathyroid hormone levels further support this diagnosis.The patient was started on calcitonin injections to help regulate calcium levels and prevent further bone complications.The patient responded well to treatment and was discharged with a follow-up appointment scheduled in two weeks to monitor calcium levels and treatment efficacy.62FemaleCaucasian"
    },
    "5699": {
        "explanation_text": "Other disorders of mineral metabolism.",
        "symptom_text": "The patient has a history of chronic kidney disease stage 3 and has been on long-term calcium and vitamin D supplements.The patient complains of generalized weakness and bone pain.Laboratory tests show elevated serum phosphorus levels and low parathyroid hormone levels.Other disorders of mineral metabolism (E8389): The patient presents with elevated serum phosphorus levels and low parathyroid hormone levels, indicative of a disorder of mineral metabolism.The patient's symptoms and lab results are consistent with a disorder of mineral metabolism, specifically showing abnormalities in phosphorus metabolism.The patient was started on phosphate binders and advised dietary modifications to manage the mineral metabolism disorder.The patient's symptoms improved with treatment, and arrangements were made for outpatient follow-up to monitor the mineral metabolism disorder.58FemaleCaucasian"
    }
}